Such findings bolster the understanding of the coordinated mechanisms between PD-L2 and PD-L1 within the tumor microenvironment and reinforce the rationale for exploring PD-L2 as an alternative immunotherapy target. Here, PDCD1LG2 is linked to neoplasm.